Previous post Next post

Swiss pharma sector could face steep US tariffs

Swiss pharma sector could face steep US tariffs
Trump: tariffs soon on pharmaceutical products and semiconductor chips too Keystone-SDA

According to US President Donald Trump, foreign pharmaceutical players will soon also have to brace themselves for steep tariffs. These would be introduced soon, Trump told journalists on board the presidential aircraft Air Force One.

Trump told reporters on Thursday that tariffs on pharmaceuticals will start coming in “at a level that we haven’t really seen before.”

“We are looking at pharma right now. Pharmaceuticals. It’s a separate category,” he said. “We’ll be announcing that sometime in the near future. It’s under review right now,” he said.

+ Get the most important news from Switzerland in your inbox

Trump announced tariffs of 10% on most US imports on Wednesday. However, he is imposing significantly higher tariffs on numerous countries with which the US has a large trade deficit, including Switzerland at 32%. However, some goods, including pharmaceuticals, have been temporarily exempted.

Healthcare stocks fell across the board on Friday. Shares of Sandoz, Novartis, Alcon, Straumann, Lonza Roche and Sonova lost up to 3.8%. Traders pointed to Trump’s latest statements on possible pharmaceutical tariffs. Initially, it had looked as if pharmaceutical products would be spared, which had supported the shares of companies such as Lonza and Novartis on Thursday.

What is your opinion? Join the debate:

External Content

Adapted from German by DeepL/ac

How we work

We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. A journalist then briefly reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team.

Did you find this explanation helpful? Please fill out the short survey on this page to help us understand your needs.

Swiss pharma sector could face steep US tariffs

More

Fewer Swiss twins after artificial insemination

This content was published on Multiple births following artificial insemination in Switzerland have fallen sharply over the last 20 years, shrinking from 17.4% in 2002 to 2.8% in 2023.

Read more: Fewer Swiss twins after artificial insemination
Full story here Are you the author?
About Swissinfo
Swissinfo
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.
Previous post See more for 3.) Swissinfo Business and Economy Next post
Tags: ,

Permanent link to this article: https://snbchf.com/2025/04/swiss-pharma-sector-face-steep-tariffs/

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

This site uses Akismet to reduce spam. Learn how your comment data is processed.